CF and non-CF bronchiectasis

Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis
Rikke M. Sandvik, Marika N. Schmidt, Christian M. Voldby, Frederik F. Buchvald, Hanne V. Olesen, Jørgen Olsen, Maja V. Kragh, Sune L.M. Rubak, Tacjana Pressler, Paul D. Robinson, Per M. Gustafsson, Marianne Skov, Kim G. Nielsen

ERJ Open Research Sep 2023, 9 (5) 00317-2023; DOI: 10.1183/23120541.00317-2023
Computed tomography reveals hypertrophic remodelling of the diaphragm in cystic fibrosis but not in COPD
Fatemeh Ostadan, Adamo A. Donovan, Elias Matouk, Francois Gabriel David, Dylan Marchand, Caroline Reinhold, Dao Nguyen, Peter Goldberg, Andrea Benedetti, Benjamin M. Smith, Basil J. Petrof

ERJ Open Research Sep 2023, 9 (5) 00282-2023; DOI: 10.1183/23120541.00282-2023
Quantitative ^99mTc-albumin colloid nasal mucociliary clearance as an outcome in primary ciliary dyskinesia
June K. Marthin, Kim G. Nielsen, Jann Mortensen

ERJ Open Research Sep 2023, 9 (5) 00345-2023; DOI: 10.1183/23120541.00345-2023
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis
Jessica Rademacher, Luise Martin, Anja Theloe, Mirjam Stahl, Marcus A. Mall, Oana Joean, Jan Fuge, Gesine Hansen, Tobias Welte, Katharina Schütz, Felix C. Ringshausen, Anna M. Dittrich

ERJ Open Research Jul 2023, 9 (4) 00356-2023; DOI: 10.1183/23120541.00356-2023
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
Raffaella Ronco, Giovanni Franco, Matteo Monzio Compagnoni, Stefano Aliberti, Fabrizio Luppi, Giovani Corrao, Paola Faverio

ERJ Open Research Jul 2023, 9 (4) 00158-2023; DOI: 10.1183/23120541.00158-2023
Pulmonary exacerbations in insured patients with bronchiectasis over 2 years
Patrick A. Flume, Joseph Feliciano, Matthew Lucci, Jasmanda Wu, Sebastian Fucile, Mariam Hassan, Anjan Chatterjee

ERJ Open Research Jul 2023, 9 (4) 00021-2023; DOI: 10.1183/23120541.00021-2023
Pseudomonas aeruginosa population genomics among adults with bronchiectasis across Germany
Ilona Rosenboom, Sibel Oguz, Idalina M. Lüdemann, Felix C. Ringshausen, Jessica Rademacher, Ludwig Sedlacek, Burkhard Tümmler, Nina Cramer

ERJ Open Research May 2023, 9 (3) 00156-2023; DOI: 10.1183/23120541.00156-2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
James D. Chalmers, Abhya Gupta, Sanjay H. Chotirmall, April Armstrong, Peter Eickholz, Naoki Hasegawa, Pamela J. McShane, Anne E. O'Donnell, Michal Shteinberg, Henrik Watz, Anastasia Eleftheraki, Claudia Diefenbach, Wiebke Sauter

ERJ Open Research May 2023, 9 (3) 00633-2022; DOI: 10.1183/23120541.00633-2022
Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole
Anne M. Akkerman-Nijland, Bart L. Rottier, Joanne Holstein, Rik L.J. Winter, Daniel J. Touw, Onno W. Akkerman, Gerard H. Koppelman

ERJ Open Research May 2023, 9 (3) 00055-2023; DOI: 10.1183/23120541.00055-2023
Endobronchial optical coherence tomography or computed tomography for evaluating progression of bronchiectasis
Lin-ling Cheng, Wei-jie Guan, Chang-hao Zhong, Chong-yang Duan, Zhu-quan Su, Shi-yue Li, Nan-shan Zhong

ERJ Open Research May 2023, 9 (3) 00490-2022; DOI: 10.1183/23120541.00490-2022

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us